Obstetrics
Shorter labor duration was observed in women given increased intravenous fluids
Published in OBGYN and Reproduction Week, July 17th, 2006
Scientists in Iran sought "to compare the effect of 2 regimens of intravenous fluid therapy on the course of labor."
"In a prospective, randomized, double-blind study of 300 nulliparous pregnant women at term conducted at a teaching hospital, 153 women received 125 mL and 147 received 250 mL of intravenous fluid per hour," explained L. Eslamian and colleagues of the Tehran University of Medical Sciences. "The groups 2 were matched and analysis was done using the t, chi-squared, and Fisher exact tests. P<0.05 was considered statistically...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Assisted Reproduction
Metformin increases pregnancy rate in infertile women after laparoscopic ovarian drilling - Obstetrics
Anal incontinence may be related to sphincter injuries following mediolateral episiotomy - Ovarian Cancer
Preoperative plasma osteopontin level may be biomarker of ovarian cancer - Spontaneous Abortion
Unexplained pregnancy loss may be linked to imbalance in CTLA-4/028 expression - Alcohol Use
Baby's first stool may provide clues to fetal alcohol exposure - Assisted Reproduction
Effects of obesity on reproductive outcomes are focus of review - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
